International Oil Price Rebounds Intraday, Hyperliquid Funding Rate Shows Overall Bearish Sentiment
BlockBeats News, March 11th, according to Hyperinsight Monitoring, international oil prices rebounded, with WTI crude oil rising more than 6% to $88.6 per barrel; Brent crude oil rose over 5% to $92.44 per barrel. Hyperliquid's contract prices also rose in sync, with CL at $88.2 and BRENTOIL at $89.7.
Despite the slight recovery in prices, the platform funding rate remains negative, indicating that the overall market sentiment is still bearish. It is worth noting that in the Perp DEX platform where CL contracts are currently available, Pacifica's funding rate is positive, with a difference of 0.0035% compared to Hyperliquid.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
